Aural Analytics‘ speech analytics software app for amyotrophic lateral sclerosis (ALS), intended for use by researchers and doctors working in the disease, has been designated a breakthrough device by the U.S. Food and Drug Administration (FDA).
- image by freepik

alsnewstoday.com
Speech Vitals, software app for ALS research and care, gains FDA support